In a study of 933 non-squamous NSCLC cases, no patients with MET gene exon 14 skipping mutation had mutations in KRAS, EGFR, and ERBB2, or rearrangements in ALK, ROS1, and RET (87). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.